Cargando…

Does Prolonged Infusion Time Really Improve the Efficacy of Meropenem Therapy? A Prospective Study in Critically Ill Patients

INTRODUCTION: Meropenem is a carbapenem antibiotic, which has demonstrated excellent antimicrobial activity against gram-negative clinical isolates. It is also commonly used in critically ill patients. This study aimed to determine the pharmacokinetics/pharmacodynamics of meropenem in critically ill...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Yi-Chang, Zou, Yang, Xiao, Yi-Wen, Wang, Feng, Zhang, Bi-Kui, Xiang, Da-Xiong, Yu, Feng, Luo, Hong, Sandaradura, Indy, Yan, Miao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8847520/ https://www.ncbi.nlm.nih.gov/pubmed/34748194 http://dx.doi.org/10.1007/s40121-021-00551-2

Ejemplares similares

Continuous infusion of meropenem in critically ill patients: practical considerations
por: Taccone, Fabio Silvio
Publicado: (2012)

C/MIC > 4: A Potential Instrument to Predict the Efficacy of Meropenem
por: Zhao, Yichang, et al.
Publicado: (2022)

Comparison of the Effectiveness of Prolonged Infusion and Intermittent Infusion of Meropenem in Patients With Sepsis: A Meta-Analysis
por: Lokhandwala, Adnan, et al.
Publicado: (2023)

Continuous infusion versus intermittent administration of meropenem in critically ill patients: a pilot study
por: Thalhammer, F, et al.
Publicado: (1999)

Impact of cumulative fluid balance on the pharmacokinetics of extended infusion meropenem in critically ill patients with sepsis
por: Pařízková, Renata Černá, et al.
Publicado: (2021)

Pharmacokinetics and Pharmacodynamics of Meropenem by Extended or Continuous Infusion in Low Body Weight Critically Ill Patients
por: Luque, Sonia, et al.
Publicado: (2021)

Factors Affecting Voriconazole Trough Concentration and Optimal Maintenance Voriconazole Dose in Chinese Children
por: Zhao, Yi-Chang, et al.
Publicado: (2021)

1547. Modeling Pharmacokinetics and Pharmacodynamics of Meropenem Utilizing a Novel Infusion Method of Bolus to Prolonged Infusion
por: Moore, Sarah E, et al.
Publicado: (2019)

Optimal loading dose of meropenem before continuous infusion in critically ill patients: a simulation study
por: Liebchen, Uwe, et al.
Publicado: (2021)

Meropenem: continuous or extended infusion?
por: Frippiat, Frédéric, et al.
Publicado: (2020)

Prolonged dexmedetomidine infusion and drug withdrawal in critically ill children
por: Haenecour, A, et al.
Publicado: (2015)

Clinical outcomes of prolonged infusion (extended infusion or continuous infusion) versus intermittent bolus of meropenem in severe infection: A meta-analysis
por: Yu, Zhenwei, et al.
Publicado: (2018)

Pharmacokinetics of meropenem in critically ill patients in Saudi Arabia
por: Alsultan, Abdullah, et al.
Publicado: (2021)

Meropenem Pharmacokinetics and Target Attainment in Critically Ill Patients
por: Gan, Yuhong, et al.
Publicado: (2023)

Intrapulmonary concentrations of meropenem administered by continuous infusion in critically ill patients with nosocomial pneumonia: a randomized pharmacokinetic trial
por: Benítez-Cano, Adela, et al.
Publicado: (2020)

Meropenem and piperacillin/tazobactam prescribing in critically ill patients: does augmented renal clearance affect pharmacokinetic/pharmacodynamic target attainment when extended infusions are used?
por: Carlier, Mieke, et al.
Publicado: (2013)

Pharmacokinetics of prolonged infusion of high-dose dexmedetomidine in critically ill patients
por: Iirola, Timo, et al.
Publicado: (2011)

The diagnosis of adrenal insufficiency in the critically ill patient: does it really matter?
por: Marik, Paul E
Publicado: (2006)

402 Pharmacokinetics of Extended vs Intermittent Intravenous Infusion of Meropenem in Critically Ill Patients Receiving Continuous Veno-Venous Haemofiltration
por: Frippiat, Frédéric, et al.
Publicado: (2014)

An investigation of the stability of meropenem in elastomeric infusion devices
por: Foy, Finbarr, et al.
Publicado: (2019)

Meropenem administration by intermittent infusion versus continuous infusion for the treatment of nosocomial pneumonia
por: Lorente, L, et al.
Publicado: (2005)

Conversion from prolonged intravenous fentanyl infusion to enteral methadone in critically ill children
por: Srinivasan, Vijay, et al.
Publicado: (2017)

Model-Informed Translation of In Vitro Effects of Short-, Prolonged- and Continuous-Infusion Meropenem against Pseudomonas aeruginosa to Clinical Settings
por: Minichmayr, Iris K., et al.
Publicado: (2022)

The Effect of Voriconazole on Tacrolimus in Kidney Transplantation Recipients: A Real-World Study
por: Zhao, Yi-Chang, et al.
Publicado: (2022)

Psychotropic Drugs and Prolonged QTc Interval: Does it Really that Matter?
por: Naguy, Ahmed
Publicado: (2016)

Does intraoperative remifentanil infusion really make more postoperative pain?
por: Son, Ji-Seon, et al.
Publicado: (2011)

Clearance of meropenem during continuous renal replacement therapy in critically ill patients
por: Thalhammer, F, et al.
Publicado: (1999)

Pharmacokinetics of meropenem during continuous renal replacement therapy in critically ill patients
por: Solé Violan, J, et al.
Publicado: (2014)

Assessment of pharmacokinetic changes of meropenem during therapy in septic critically ill patients
por: Goncalves-Pereira, João, et al.
Publicado: (2014)

Meropenem-Resistant Pandoraea Pneumonia in a Critically Ill Patient With COVID-19
por: Dlewati, Mohammad M, et al.
Publicado: (2021)

Continuous infusion of meropenem–vaborbactam for a KPC-3-producing Klebsiella pneumoniae bloodstream infection in a critically ill patient with augmented renal clearance
por: Larcher, Romaric, et al.
Publicado: (2023)

Impact of High Body Weight on Mortality in Critically Ill Patients Receiving Meropenem for Pneumonia
por: Gao, Xiaofang, et al.
Publicado: (2019)

Evaluation of pharmacokinetic and pharmacodynamic parameters of meropenem in critically ill patients with acute kidney disease
por: Hassanpour, Rezvan, et al.
Publicado: (2021)

Population Pharmacokinetics of Meropenem in Critically Ill Korean Patients and Effects of Extracorporeal Membrane Oxygenation
por: Lee, Dong-Hwan, et al.
Publicado: (2021)

The effect of meropenem versus piperacillin-tazobactam in critically ill patients with sepsis and septic shock()
por: Sun, Yang, et al.
Publicado: (2023)

Continuous Infusions of Meropenem in Ambulatory Care: Clinical Efficacy, Safety and Stability
por: Manning, Laurens, et al.
Publicado: (2014)

Extended Infusion of Meropenem in Neonatal Sepsis: A Historical Cohort Study
por: Cao, Guangna, et al.
Publicado: (2022)

Improving the efficacy for meropenem therapy requires a high probability of target attainment in critically ill infants and children
por: Wang, Zeming, et al.
Publicado: (2022)

Reply: Does a Capsulectomy Really Improve Pulmonary Function in Women with Breast Implant Illness?
por: Feng, Lu-Jean, et al.
Publicado: (2021)

Does ruxolitinib really prolong survival in individuals with myelofibrosis? The never-ending story
por: Barosi, Giovanni, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_mf4mscq9g9b7lref7qkqbgktvf